Polymorphisms in TGFB1 and PDGFRB are associated with Moyamoya disease in European patients

[1]  D. Tregouet,et al.  A rare Asian founder polymorphism of Raptor may explain the high prevalence of Moyamoya disease among East Asians and its low prevalence among Caucasians , 2010, Environmental health and preventive medicine.

[2]  R. Scott,et al.  Moyamoya disease and moyamoya syndrome. , 2009, The New England journal of medicine.

[3]  K. Wang,et al.  Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[4]  Robert K. Yu,et al.  Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease. , 2009, American journal of human genetics.

[5]  R. Guzman,et al.  Pathophysiology and genetic factors in moyamoya disease. , 2009, Neurosurgical focus.

[6]  R. Weiskirchen,et al.  Non-synonymous gene polymorphisms in the secretory signal peptide of human TGF-beta1 affect cellular synthesis but not secretion of TGF-beta1. , 2009, Biochemical and biophysical research communications.

[7]  K. Nozaki,et al.  Autosomal dominant moyamoya disease maps to chromosome 17q25.3 , 2008, Neurology.

[8]  T. Yoshimoto,et al.  Prevalence and Clinicoepidemiological Features of Moyamoya Disease in Japan: Findings From a Nationwide Epidemiological Survey , 2008, Stroke.

[9]  K. Nozaki,et al.  Inheritance pattern of familial moyamoya disease: autosomal dominant mode and genomic imprinting , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[10]  K. Wang,et al.  Single Nucleotide Polymorphisms of Tissue Inhibitor of Metalloproteinase Genes in Familial Moyamoya Disease , 2006, Neurosurgery.

[11]  E. Raines.  PDGF and cardiovascular disease. , 2004, Cytokine & growth factor reviews.

[12]  M. Fukui,et al.  A novel susceptibility locus for moyamoya disease on chromosome 8q23 , 2004, Journal of Human Genetics.

[13]  K. Wang,et al.  Elevation of CRABP-I in the Cerebrospinal Fluid of Patients With Moyamoya Disease , 2003, Stroke.

[14]  B. Berk,et al.  Retinoids: versatile biological response modifiers of vascular smooth muscle phenotype. , 2000, Circulation research.

[15]  Toshihiro Tanaka,et al.  Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. , 2000, Stroke.

[16]  M. Fukui,et al.  Linkage Analysis of Moyamoya Disease on Chromosome 6 , 2000, Journal of child neurology.

[17]  M. Fukui,et al.  Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. , 1999, American journal of human genetics.

[18]  K. Houkin,et al.  Role of basic fibroblast growth factor in the pathogenesis of moyamoya disease. , 1998, Neurosurgical focus.

[19]  S. Miyamoto,et al.  Role of transforming growth factor-beta1 in the pathogenesis of moyamoya disease. , 1998, Journal of neurosurgery.

[20]  M. Aoyagi,et al.  Differences in cellular responses to mitogens in arterial smooth muscle cells derived from patients with moyamoya disease. , 1998, Stroke.

[21]  Y. Yonekawa,et al.  Moyamoya disease in Europe, past and present status , 1997, Clinical Neurology and Neurosurgery.

[22]  R. Scott,et al.  Elevation of cerebrospinal fluid levels of basic fibroblast growth factor in moyamoya and central nervous system disorders. , 1997, Pediatric neurosurgery.

[23]  A. Takahashi,et al.  Angiogenic factors in moyamoya disease. , 1996, Stroke.

[24]  R. Ross.  The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[25]  M. Aoyagi,et al.  Kinetics of 125I‐PDGF binding and down‐regulation of PDGF receptor in arterial smooth muscle cells derived from patients with moyamoya disease , 1993, Journal of cellular physiology.

[26]  J. Takahashi,et al.  Possible roles of basic fibroblast growth factor in the pathogenesis of moyamoya disease: an immunohistochemical study. , 1991, Journal of neurosurgery.

[27]  M. Aoyagi,et al.  Altered cellular responses to serum mitogens, including platelet‐derived growth factor, in cultured smooth muscle cells derived from arteries of patients with moyamoya disease , 1991, Journal of cellular physiology.

[28]  A Takaku,et al.  Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. , 1969, Archives of neurology.

[29]  Y. Takagi.  Vascular Smooth Muscle Cell-Related Molecules and Cells , 2010 .

[30]  Y. Yonekawa,et al.  Moyamoya angiopathy in Europe. , 2005, Acta neurochirurgica. Supplement.

[31]  S. Kuroda,et al.  Sequence analysis and bioinformatics analysis of chromosome 17q25 in familial moyamoya disease , 2004, Child's Nervous System.